221 related articles for article (PubMed ID: 22815500)
1. Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.
Wu F; Wu J; Nicholson AD; Echeverry R; Haile WB; Catano M; An J; Lee AK; Duong D; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Medcalf RL; Yepes M
J Neurosci; 2012 Jul; 32(29):9848-58. PubMed ID: 22815500
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.
Wu F; Nicholson AD; Haile WB; Torre E; An J; Chen C; Lee AK; Duong DM; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Yepes M
J Cereb Blood Flow Metab; 2013 Nov; 33(11):1761-9. PubMed ID: 23881246
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.
An J; Haile WB; Wu F; Torre E; Yepes M
Neuroscience; 2014 Jan; 257():41-8. PubMed ID: 24200922
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.
Yepes M
Front Cell Neurosci; 2015; 9():304. PubMed ID: 26347605
[TBL] [Abstract][Full Text] [Related]
5. tPA promotes cortical neuron survival via mTOR-dependent mechanisms.
Grummisch JA; Jadavji NM; Smith PD
Mol Cell Neurosci; 2016 Jul; 74():25-33. PubMed ID: 26995507
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
[TBL] [Abstract][Full Text] [Related]
7. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen.
Hobohm C; Laignel F; Kacza J; Küppers-Tiedt L; Heindl M; Schneider D; Grosche J; Härtig W; Michalski D
Brain Res; 2011 Oct; 1417():115-26. PubMed ID: 21914554
[TBL] [Abstract][Full Text] [Related]
9. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.
Thiebaut AM; Buendia I; Ginet V; Lemarchand E; Boudjadja MB; Hommet Y; Lebouvier L; Lechevallier C; Maillasson M; Hedou E; Déglon N; Oury F; Rubio M; Montaner J; Puyal J; Vivien D; Roussel BD
Autophagy; 2022 Jun; 18(6):1297-1317. PubMed ID: 34520334
[TBL] [Abstract][Full Text] [Related]
11. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
[TBL] [Abstract][Full Text] [Related]
12. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
14. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.
Yepes M
Neuroscience; 2024 Mar; 542():69-80. PubMed ID: 37574107
[TBL] [Abstract][Full Text] [Related]
16. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
[TBL] [Abstract][Full Text] [Related]
17. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
18. Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.
Lemarchand E; Maubert E; Haelewyn B; Ali C; Rubio M; Vivien D
Cell Death Differ; 2016 Jan; 23(1):123-31. PubMed ID: 26068590
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
[TBL] [Abstract][Full Text] [Related]
20. Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke.
Pu H; Shi Y; Zhang L; Lu Z; Ye Q; Leak RK; Xu F; Ma S; Mu H; Wei Z; Xu N; Xia Y; Hu X; Hitchens TK; Bennett MVL; Chen J
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9115-9124. PubMed ID: 30996120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
